Corrigendum to "Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia" [Bioact. Mater. 21 (March 2023) 499-510].

Bioactive Materials（2024）

引用 0|浏览12

暂无评分

摘要

[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].

查看译文

关键词

clinical plk1 inhibitor,intelligent nanovesicles,myeloid leukemia”,transferrin-guided

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要